Document is current

Article History

Received: 7 July 2021

Accepted: 2 June 2022

First Online: 24 August 2022

Declarations

:

: Ethical approval for the study was obtained from the University of Birmingham ethics committee (ethics code: ERN_16-0041) and all participants provided written informed consent. The procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation and with the Declaration of Helsinki.

: Not applicable<b>.</b>

: KR reports grants and personal fees from AbbVie, grants and personal fees from Pfizer, personal fees from Sanofi, personal fees from Lilly, personal fees from Bristol Myers Squibb, personal fees from UCB, personal fees from Janssen, and personal fees from Roche Chugai, outside the submitted work. CM is funded by the National Institute for Health Research (NIHR) Applied Research Collaboration West Midlands and the National Institute for Health Research (NIHR) School for Primary Care Research. Keele School of Medicine have received funding from BMS to support a non-pharmacological AF screening trial. SP is Programme Director for a national eLearning programme (SCRIPT), developed by the University of Birmingham and funded by Health Education England. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. All other authors declare no competing interests.